Marco Cirillo | Interactive Analytics | Best Researcher Award

Dr. Marco Cirillo | Interactive Analytics | Best Researcher Award

Non-Profit Polyambulance Foundation | Italy

Dr. Marco Cirillo is a distinguished cardiac surgeon whose career seamlessly bridges clinical excellence and experimental research. After completing classical studies, he graduated in Medicine and Surgery with highest honors  from the University of Bologna and specialized in Cardiac and Great Vessels Surgery. His career has encompassed leadership roles as Head of the Cardiac Surgery Unit in Bologna for six years and the Heart Failure Surgery Unit in Brescia for twelve years. With expertise spanning the full range of traditional cardiac surgery-including mitral repair, coronary bypass, valve replacement, and aortic arch procedures-Dr. Cirillo has performed over 8,000 surgeries as first surgeon. His innovative contributions include the KISS procedure for physiological left ventricular reconstruction, the “Arterial-source No-touch Aorta” technique for off-pump coronary revascularization, and the NINFEA method for annular stabilization in endocarditis. Renowned for his commitment to quality and risk management (JCI accreditation), he continues to advance the field through research on bioprostheses and ventricular assist systems, recognized internationally through publications and awards. In 2025, he earned a Master’s degree in Echocardiography from the University of Verona. Beyond medicine, his intellectual pursuits extend to writing, photography, and cosmology, where he recently published a paper exploring Darwinian natural evolution as applied to the development of the Universe.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

"Achilles and the Tortoise: Rethinking Evidence Generation in Cardiovascular Surgery and Interventional Cardiology", Marco Cirillo, Hearts, 2025.

"Abiotrophia defectiva and Granulicatella: A Literature Review on Prosthetic Joint Infection and a Case Report on defectiva PJI and Concurrent Native Valve Endocarditis", MCristina Seguiti; Edda Piacentini; Angelica Fraghì; Mattia Zappa; Elia Croce; Angelo Meloni; Marco Cirillo; Clarissa Ferrari; Chiara Zani; David Belli et al., Microorganisms, 2025.

"Finger ischemia in a young lady: an unusual presentation of papillary fibroelastoma with intraventricular location", Matteo Pernigo; Elisabetta Dinatolo; Marco Cirillo; Zean Mhagna; Alida Filippini; Fabiana Cozza; Marco Berti; Roberto Bazzani; Tony Sabatini; Claudio Cuccia et al., Monaldi Archives for Chest Disease, 2023.

"Exploring Personal Protection During High-Risk PCI in a COVID-19 Patient", Marco Cirillo, JACC: Case Reports, 2020.

Xiaosuo Wang | Technological Networks | Best Researcher Award

Dr. Xiaosuo Wang | Technological Networks | Best Researcher Award

The University of Sydney | Australia

Dr. Xiaosuo Wang is a distinguished researcher specializing in mass spectrometry, metabolomics, lipidomics, and proteomics, with deep expertise in vascular biology and heart failure. She earned her PhD in Medicine from the University of Sydney in 2009, focusing on novel ELISA methods to detect oxidised apolipoproteins in cardiovascular disease, following a master’s degree in Physiology and Pharmacology from the University of New South Wales and a bachelor’s in Biomedical Engineering from the Fourth Military Medical University, China. Currently a Senior Research Fellow and Senior Lecturer at the University of Sydney’s Charles Perkins Centre, she leads pioneering projects in biomarker discovery, metabolic assays, and multi-omics platform development for applications in liver disease, heart failure, and population health. Her work integrates advanced mass spectrometry, lipidomics, and metabolomics workflows with translational innovations such as point-of-care assays and biosensor development. Previously, as a Metabolomics Research Scientist at the Victor Chang Cardiac Research Institute and Manager of the Bosch Mass Spectrometry Facility, she developed over 60 advanced LC-MS assays and supported a wide range of biological and clinical research. Dr. Wang’s prolific contributions include more than 40 peer-reviewed publications, numerous conference presentations, and significant advancements in analytical methodologies for precision medicine.

Profiles: Scopus | Orcid ID

Featured Publications

"Rapid On-Demand Point-of-Care Monitoring of Clozapine and Its Metabolite Norclozapine Using Miniature Mass Spectrometry. Pharmaceuticals, Xiaosuo Wang; Wei Yi Lew; Yang Yang; Nan Zhang; Jiexun Bu; Zhentao Li; Michael Fitzpatrick; Paul Bonnitcha; David Sullivan; Wenpeng Zhang et al., 2025"

"The Heart Has Intrinsic Ketogenic Capacity that Mediates NAD + Therapy in HFpEF, Circulation Research, Yen Chin Koay; Bailey McIntosh; Yann Huey Ng; Yang Cao; Xiao Suo Wang; Yanchuang Han; Saki Tomita; Angela Yu Bai; Benjamin Hunter; Ashish Misra et al., 2025"

"Cardiac Substrate Utilization and Relationship to Invasive Exercise Hemodynamic Parameters in HFpEF, JACC. Basic to translational science, O'Sullivan JF; Li M; Koay YC; Wang XS; Guglielmi G; Marques FZ; Nanayakkara S; Mariani J; Slaughter E; Kaye DM, 2024"

"The first human normative ranges and biomarker performance of dimethylguanidino valeric acid isoforms in fatty liver disease, Pathology, Qadri S; Wang X; Tran C; Fitzpatrick M; Bonnitcha P; Sullivan D; Yki-Järvinen H; O'Sullivan JF, 2023"

"Destabilization of Atherosclerotic Plaque by Bilirubin Deficiency, Circulation Research, Weiyu Chen; Sergey Tumanov; Christopher P. Stanley; Stephanie M.Y. Kong; James Nadel; Niv Vigder; Darren L. Newington; Xiao Suo Wang; Louise L. Dunn; Roland Stocker, 2025"